Pharmavite Ratings Supplement Profitability for Cancer Patients

The present study was performed by the supplement manufacturer, Pharmavite, to examine the prevalence and cost-effectiveness of dietary supplementation in cancer patients.

The results revealed that cancer survivors using DS had a significantly lower rate of hospitalizations and reported better quality of life (QOL) compared to survivors not taking supplements, with notable additional savings.

The researchers say: “The gold standard is to obtain adequate nutritional intake through food sources, although nutrient adequacy is often not achieved for a variety of reasons, including side effects of treatment.Have

Study parametersHave

The researchers performed a population-level analysis to explore the impact of long-term DS use on “quality-adjusted life years ”,and the potential for profitability in a cancer population, with and without supplementation.

The cost of the supplements was derived from national drug databases, including single vitamins and multivitamins, and estimated using online retail prices from major brands.

The study cohort represented the national cancer survivor population (mean age 61, 85% white, 52% males, and 94% insured).

Most had a regular health care provider (93.7%) and the vast majority had some form of insurance (94.4%).

More than two-thirds of the sample (68%) said they had used some form of vitamin or DS in the past 30 days.

Positive resultsHave

Hospitalization rates have been used as a key marker of the quality of cancer care and have emerged as the primary driver of cancer-related health care spending (aside from primary tumor resection) in cancer patients, write the authors of the study.

Clinical admissions for supplement users versus non-users were 12% and 21%, respectively, at an average cost of € 3,516 ($ 4,030).

The supplements were associated with additional additional costs of € 1,827 ($ 2,094), over the remaining lifespan of the survivors (average 13 years).

Sensitivity analysis of lower and upper thresholds of life expectancy (from one to 20 years) and incremental costs demonstrated that after six years of supplementation, the benefit of lower hospitalization rates in DS users l outweighs the cost of dietary supplementation.

The authors therefore state that: “Immune support supplementation may prove to be a clinically effective and important tool that is accessed through telemedicine.”Have

Risk of malnutrition

Cancer and its treatments have a serious negative impact on the body’s ability to consume and absorb nutrients. As a result, both patients and survivors are at risk for malnutrition. In the United States, adult cancer survivors currently spend about 5.9 billion euros ($ 6.8 billion) on dietary supplements (DS) each year.

However, there are significant variations in prices and formulations and there is little value for money evidence.

This limits the ability of patients to make informed decisions about the pros and cons of supplements.

Although their use in cancer patients is common, the approach remains controversial and experts recommend caution due to possible interactions with chemotherapy.

Studies suggest that the benefits of DS depend on factors such as the type and treatment of cancer, and the recommended approach for “nutritional therapy“for cancer survivors is a combination of daily food intake, dietary supplementation, and prescribed nutritional therapy.

A significant proportion of patients and survivors are turning to supplements to lessen the side effects of cancer treatment: to improve immune function, reduce nutritional deficiencies and prevent recurrence of the disease.

Further researchHave

Despite the positive results, the limitations of the study make further research necessary to assess the role and duration of SD in cancer patients to determine the level of dose-response,

The research team also recommends further study of the role of supplements on various co-morbidities and side effects in cancer survivors, such as cardiovascular disease, diabetes, and other metabolic disorders.

Further clarification on the mechanism of the effects of DS on the modulation of the immune system is also recommended.

Source: CancersHave

Posted:, doi.org/10.3390/cancers13246276Have

“Cost-Effectiveness of Nutrient Supplementation in Cancer Survivors” Have

Amy Shaver et al,

Comments are closed.